Development of a quantitative real-time RT-PCR assay for the detection of MAGE-A3-positive tumors

Journal of Molecular Diagnostics

Volumn 17, Issue 4, 2015, Pages 382-391

  Gruselle, Olivier ^a   Coche, Thierry ^a   Louahed, Jamila ^a  

^a GSK   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN A6; UNCLASSIFIED DRUG; MAGEA3 PROTEIN, HUMAN; MESSENGER RNA; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER IMMUNOTHERAPY; CELL CULTURE; CROSS REACTION; GENE EXPRESSION; HUMAN; HUMAN CELL; NEOPLASM; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; CARCINOMA, NON-SMALL-CELL LUNG; GENETICS; LUNG NEOPLASMS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROCEDURES; SEQUENCE HOMOLOGY;

ANTIGENS, NEOPLASM; BASE SEQUENCE; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84931323127     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.03.008     Document Type: Article

References (27)

1. P. van der Bruggen, C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 254 1991 1643 1647
2. P. Chomez, O. De Backer, M. Bertrand, E. De Plaen, T. Boon, and S. Lucas An overview of the MAGE gene family with the identification of all human members of the family Cancer Res 61 2001 5544 5551
3. E. De Plaen, K. Arden, C. Traversari, J.J. Gaforio, J.-P. Szikora, C. De Smet, F. Brasseur, P. van der Bruggen, B. Lethé, C. Lurquin, R. Brasseur, P. Chomez, O. De Backer, W. Cavenee, and T. Boon Structure, chromosomal localization, and expression of 12 genes of the MAGE family Immunogenetics 40 1994 360 369
4. M. Sang, Y. Lian, X. Zhou, and B. Shan MAGE-A family: attractive targets for cancer immunotherapy Vaccine 29 2011 8496 8500
5. K. Takahashi, S. Shichijo, M. Noguchi, M. Hirohata, and K. Itoh Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis Cancer Res 55 1995 3478 3482
6. C. De Smet, O. De Backer, I. Faraoni, C. Lurquin, F. Brasseur, and T. Boon The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation Proc Natl Acad Sci U S A 93 1996 7149 7153
7. C. De Smet, C. Lurquin, B. Lethé, V. Martelange, and T. Boon DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter Mol Cell Biol 19 1999 7327 7335
8. F. Brasseur, D. Rimoldi, D. Liénard, B. Lethé, S. Carrel, F. Arienti, L. Suter, R. Vanwijck, A. Bourlond, Y. Humblet, A. Vacca, M. Conese, T. Lahaye, G. Degiovanni, R. Deraemaecker, M. Beauduin, X. Sastre, E. Salamon, B. Dréno, E. Jäger, A. Knuth, C. Chevreau, S. Suciu, J.-M. Lachapelle, P. Pouillard, G. Parmiani, F. Lejeune, J.-C. Cerottini, T. Boon, and M. Marchand Expression of MAGE genes in primary and metastatic cutaneous melanoma Int J Cancer 63 1995 375 380
9. J. Ries, N. Mollaoglu, T. Toyoshima, E. Vairaktaris, F.W. Neukam, S. Ponader, and E. Nkenke A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma Dis Markers 27 2009 75 84
10. S.J. Jang, J.-C. Soria, L. Wang, K.A. Hassan, R.C. Morice, G.L. Walsh, W.K. Hong, and L. Mao Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis Cancer Res 61 2001 7959 7963
11. M. Otte, M. Zafrakas, L. Riethdorf, U. Pichlmeier, T. Löning, F. Jänicke, and K. Pantel MAGE-A gene expression pattern in primary breast cancer Cancer Res 61 2001 6682 6687
12. J. Lin, L. Lin, D.G. Thomas, J.K. Greenson, T.J. Giordano, G.S. Robinson, R.A. Barve, F.A. Weishaar, J.M.G. Taylor, M.B. Orringer, and D.G. Beer Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants Clin Cancer Res 10 2004 5708 5716
13. A. Bergeron, V. Picard, H. LaRue, F. Harel, H. Hovington, L. Lacombe, and Y. Fradet High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer Int J Cancer 125 2009 1365 1371
14. T. Suyama, H. Ohashi, H. Nagai, S. Hatano, H. Asano, T. Murate, H. Saito, and T. Kinoshita The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies Leuk Res 26 2002 1113 1118
15. V.G. Brichard, and D. Lejeune GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development Vaccine 25 Suppl 2 2007 B61 B71
16. N. Zammatteo, L. Lockman, F. Brasseur, E. De Plaen, C. Lurquin, P.-E. Lobert, S. Hamels, T. Boon, and J. Remacle DNA microarray to monitor the expression of MAGE-A genes Clin Chem 48 2002 25 34
17. B. Lethé, P. van der Bruggen, F. Brasseur, and T. Boon MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte Melanoma Res 7 1997 S83 S88
18. A.I. Riker, U.S. Kammula, M.C. Panelli, E. Wang, G.A. Ohnmacht, S.M. Steinberg, S.A. Rosenberg, and F.M. Marincola Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes Int J Cancer 86 2000 818 826
19. Y. Guilloux, S. Lucas, V.G. Brichard, A. Van Pel, C. Viret, E. De Plaen, F. Brasseur, B. Lethé, F. Jotereau, and T. Boon A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene J Exp Med 183 1996 1173 1183
20. W. Sienel, I. Mecklenburg, S. Dango, P. Ehrhardt, A. Kirschbaum, B. Passlick, and K. Pantel Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer Clin Cancer Res 13 2007 3840 3847
21. A.A. Jungbluth, K.J. Busam, D. Kolb, K. Iversen, K. Coplan, Y.T. Chen, G.C. Spagnoli, and L.J. Old Expression of MAGE-antigens in normal tissues and cancer Int J Cancer 85 2000 460 465
22. A.A. Jungbluth, E. Stockert, Y.T. Chen, D. Kolb, K. Iversen, K. Coplan, B. Williamson, N. Altorki, K.J. Busam, and L.J. Old Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours Br J Cancer 83 2000 493 497
23. W.H.J. Kruit, S. Suciu, B. Dreno, L. Mortier, C. Robert, V. Chiarion-Sileni, M. Maio, A. Testori, T. Dorval, J.-J. Grob, J.C. Becker, A. Spatz, A.M.M. Eggermont, J. Louahed, F.F. Lehmann, V.G. Brichard, and U. Keilholz Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma J Clin Oncol 31 2013 2413 2420
24. J. Vansteenkiste, M. Zielinski, A. Linder, J. Dahabreh, E.E. Gonzalez, W. Malinowski, M. Lopez-Brea, T. Vanakesa, J. Jassem, H. Kalofonos, J. Perdeus, R. Bonnet, J. Basko, R. Janilionis, B. Passlick, T. Treasure, M. Gillet, F.F. Lehmann, and V.G. Brichard Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results J Clin Oncol 31 2013 2396 2403
25. S. Karimi, F. Mohammadi, M. Porabdollah, S.A. Mohajerani, K. Khodadad, and S.A. Nadji Characterization of melanoma-associated antigen-a genes family differential expression in non-small-cell lung cancers Clin Lung Cancer 13 2012 214 219
26. N. Yanagawa, G. Tamura, H. Oizumi, M. Endoh, and T. Motoyama MAGE expressions mediated by demethylation of MAGE promoters induce progression of non-small cell lung cancer Anticancer Res 31 2011 171 175
27. S.H. Kim, S. Lee, C.H. Lee, M.K. Lee, Y.D. Kim, D.H. Shin, K.U. Choi, J.Y. Kim, D.Y. Park, and M.Y. Sol Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration Lung 187 2009 401 411